Literature DB >> 25663095

Long-term transmission of measles virus in Central and continental Western Europe.

S Santibanez1, J M Hübschen, C P Muller, F Freymuth, M M Mosquera, M Ben Mamou, M N Mulders, K E Brown, R Myers, A Mankertz.   

Abstract

The World Health Organization (WHO) has adopted an elimination goal for measles and rubella, which is supposed to be met in the WHO European Region (EUR) by 2015. For verification of elimination, it is required that the genotyping data of detected measles viruses provide evidence for the interruption of endemic transmission. In order to record and assess the extent of endemic measles virus (MV) circulation in a part of the EUR, we analyzed transmission chains of the epidemiologically most relevant MV variants identified in Central and continental Western Europe (CCWE) from 2006 to 2013. Based on MV sequence data deposited in the WHO global database for molecular surveillance of measles (MeaNS), the circulation period was calculated for each MV variant at the country-level and for the entire region of CCWE. The MV variants "D5-Okinawa," "D4-Hamburg," "D4-Manchester," and "D8-Frankfurt-Main" spread widely in CCWE; they caused large and long-lasting outbreaks with secondary spread that resulted in additional outbreaks. Nation-wide outbreaks (epidemics) with thousands of measles cases occurred in four countries (Switzerland, France, Bulgaria, and Romania) and were characterized by continuous detection of the same MV variant for more than 12 months suggesting endemic transmission. In the entire region of CCWE, the circulation period of the four predominant MV variants ranged from 18 to 44 months. The long-lasting MV transmission which affected predominantly unvaccinated individuals in different hard-to-reach groups and in the general population is not consistent with the measles elimination goal. Additional efforts are necessary to meet the elimination target in the EUR.

Entities:  

Mesh:

Year:  2015        PMID: 25663095     DOI: 10.1007/s11262-015-1173-1

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  22 in total

1.  Measles elimination in the United States.

Authors:  Walter A Orenstein; Mark J Papania; Melinda E Wharton
Journal:  J Infect Dis       Date:  2004-05-01       Impact factor: 5.226

2.  An outbreak of measles in Lower Bavaria, Germany, January-June 2007.

Authors:  H Bernard; S Santibanez; A Siedler; M S Ludwig; R Fischer; W Hautmann
Journal:  Euro Surveill       Date:  2007-10-04

3.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

Authors:  Koichiro Tamura; Joel Dudley; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2007-05-07       Impact factor: 16.240

Review 4.  The measles virus replication cycle.

Authors:  B K Rima; W P Duprex
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 5.  Duration of live measles vaccine-induced immunity.

Authors:  L E Markowitz; S R Preblud; P E Fine; W A Orenstein
Journal:  Pediatr Infect Dis J       Date:  1990-02       Impact factor: 2.129

6.  Two outbreaks of measles in Germany 2005.

Authors:  A Siedler; A Tischer; A Mankertz; S Santibanez
Journal:  Euro Surveill       Date:  2006

7.  Transmission and molecular characterisation of wild measles virus in Romania, 2008 to 2012.

Authors:  G Necula; M Lazar; A Stanescu; A Pistol; S Santibanez; A Mankertz; E Lupulescu
Journal:  Euro Surveill       Date:  2013-12-12

8.  Temporal and geographical distribution of measles virus genotypes.

Authors:  B K Rima; J A Earle; R P Yeo; L Herlihy; K Baczko; V ter Meulen; J Carabaña; M Caballero; M L Celma; R Fernandez-Muñoz
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

9.  Measles elimination efforts and 2008-2011 outbreak, France.

Authors:  Denise Antona; Daniel Lévy-Bruhl; Claire Baudon; François Freymuth; Mathieu Lamy; Catherine Maine; Daniel Floret; Isabelle Parent du Chatelet
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

10.  Wild-type measles viruses with non-standard genome lengths.

Authors:  Bettina Bankamp; Chunyu Liu; Pierre Rivailler; Jayati Bera; Susmita Shrivastava; Ewen F Kirkness; William J Bellini; Paul A Rota
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

View more
  7 in total

1.  Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.

Authors:  Miguel Ángel Muñoz-Alía; Claude P Muller; Stephen J Russell
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

2.  Incomplete vaccination coverage in European children with end-stage kidney disease prior to renal transplantation.

Authors:  Britta Höcker; Martin Aguilar; Paul Schnitzler; Lars Pape; Luca Dello Strologo; Nicholas J A Webb; Martin Bald; Gurkan Genc; Heiko Billing; Jens König; Anja Büscher; Markus J Kemper; Stephen D Marks; Martin Pohl; Marianne Wigger; Rezan Topaloglu; Susanne Rieger; Kai Krupka; Thomas Bruckner; Alexander Fichtner; Burkhard Tönshoff
Journal:  Pediatr Nephrol       Date:  2017-10-05       Impact factor: 3.714

3.  Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany.

Authors:  C Schwarze-Zander; R Draenert; C Lehmann; M Stecher; C Boesecke; S Sammet; J C Wasmuth; U Seybold; D Gillor; U Wieland; T Kümmerle; C P Strassburg; A Mankertz; A M Eis-Hübinger; G Jäger; G Fätkenheuer; J R Bogner; J K Rockstroh; J J Vehreschild
Journal:  Epidemiol Infect       Date:  2016-10-26       Impact factor: 4.434

4.  The World Health Organization Measles Programmatic Risk Assessment Tool-Romania, 2015.

Authors:  Jennifer L Kriss; Aurora Stanescu; Adriana Pistol; Cassandra Butu; James L Goodson
Journal:  Risk Anal       Date:  2016-07-20       Impact factor: 4.302

Review 5.  Eradication of measles: remaining challenges.

Authors:  Heidemarie Holzmann; Hartmut Hengel; Matthias Tenbusch; H W Doerr
Journal:  Med Microbiol Immunol       Date:  2016-03-02       Impact factor: 3.402

6.  Needle-free delivery of measles virus vaccine to the lower respiratory tract of non-human primates elicits optimal immunity and protection.

Authors:  Rik L de Swart; Rory D de Vries; Linda J Rennick; Geert van Amerongen; Stephen McQuaid; R Joyce Verburgh; Selma Yüksel; Alwin de Jong; Ken Lemon; D Tien Nguyen; Martin Ludlow; Albert D M E Osterhaus; W Paul Duprex
Journal:  NPJ Vaccines       Date:  2017-08-01       Impact factor: 7.344

7.  Measles virus genotype D4 strains with non-standard length M-F non-coding region circulated during the major outbreaks of 2011-2012 in Spain.

Authors:  Horacio Gil; Aurora Fernández-García; María Mar Mosquera; Judith M Hübschen; Ana M Castellanos; Fernando de Ory; Josefa Masa-Calles; Juan E Echevarría
Journal:  PLoS One       Date:  2018-07-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.